C Kainz

No ORCID on file · 4 papers in corpus · active 1996-1998

Study types

  • article 2
  • other 2

Condition tags

  • endometriosis 4
other 1998
British journal of cancer ·doi:10.1038/bjc.1998.636

The aim of the present study was to evaluate the clinical usefulness of the cytokeratin marker CYFRA 21-1 as a screening marker for ovarian cancer, as a predictive marker in patients with adnexal masses and as a prognostic marker in women s…

other 1998
Wiener klinische Wochenschrift

The aim of the present study was to evaluate the clinical usefulness of the cytokeratin tumor marker M3/M21 as a screening, prognostic, and monitoring marker for ovarian cancer and as a predictive marker in patients with adnexal masses. In …

article 1998
International journal of cancer ·doi:10.1002/(sici)1097-0215(19980821)79:4<434::aid-ijc21>3.0.co;2-3

The aim of the present study was to evaluate the clinical usefulness of the cytokeratin tumor marker M3/M21 as a screening marker for ovarian cancer, as a predictive marker in patients with adnexal masses and as a prognostic factor in women…

article 1996
Wiener medizinische Wochenschrift (1946)

Up to now no benefit of screening for ovarian cancer, using serum tumormarker and/or sonography has been proven. The following problems have to be taken into consideration: 1) With the low prevalence of ovarian cancer a screening test would…